Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroimaging Reveals Treatment-related Changes in DLD: A Randomized Controlled Trial (Supplement)

NCT06156865 is registered in ClinicalTrials.gov with University of Toronto as lead sponsor.

NCT NCT06156865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06156865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroimaging Reveals Treatment-related Changes in DLD: A Randomized Controlled Trial (Supplement)
Lead sponsor
University of Toronto
Phase
Not applicable
Overall status
Recruiting
Start date
January 19, 2024
Completion date
June 30, 2027
Enrollment
45 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

developmental language disorder, language delay, language development